Drawing for HYMITGA

USPTO serial 86349905

HYMITGA

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
SINGH, TEJBIR
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with HYMITGA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christopher M. Hanes

CHRISTOPHER M. HANES GlaxoSmithKlineFive Moore DriveLegal Global Trademarks, Mailstop: 5.5AResearch Triangle Park, NC 27709-0183

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; VaccinesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Mar 14, 2016MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 14, 2016ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 11, 2015NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 23, 2015TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 16, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 16, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 27, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 12, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 12, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 11, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 11, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 4, 2015ALIEASSIGNED TO LIE—
Apr 30, 2015ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Nov 10, 2014GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Nov 10, 2014GNSLLETTER OF SUSPENSION E-MAILED—
Nov 10, 2014CNSLSUSPENSION LETTER WRITTEN—
Nov 10, 2014DOCKASSIGNED TO EXAMINER—
Aug 5, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 31, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance